Background and purpose To assess neurological manifestations and health‐related quality
of life (QoL) 3 months after COVID‐19. Methods In this prospective, multicenter …

Background and purpose Neurological sequelae from coronavirus disease 2019 (COVID‐
19) may persist after recovery from acute infection. Here, the aim was to describe the natural …

Background Clinical investigations have argued for long-term neurological manifestations in
both hospitalised and non-hospitalised COVID-19 patients. It is unclear whether long-term …

Background Little is known regarding long-term outcomes of patients hospitalized with
COVID-19. Methods We conducted a prospective study of 6-month outcomes of hospitalized …

Central and peripheral nervous system involvement during acute COVID-19 is well known.
Although many patients report some subjective symptoms months after the infection, the …

Importance Neurological and neuropsychiatric symptoms that persist or develop three
months after the onset of COVID-19 pose a significant threat to the global healthcare system …

Abstract Objective Most SARS‐CoV‐2‐infected individuals never require hospitalization.
However, some develop prolonged symptoms. We sought to characterize the spectrum of …

Objective Covid‐19 can involve multiple organs including the nervous system. We sought to
characterize the neurologic manifestations, their risk factors, and associated outcomes in …

Backgrounds The reports of neurological symptoms are increasing in cases with coronavirus
disease 2019 (COVID-19). This multi-center prospective study was conducted to determine …

Objective We characterized the evolution of neurologic symptoms and self‐perceived
recovery of non‐hospitalized COVID‐19 “long haulers” 6–9 months after their initial Neuro …